---
title: "Enveric Biosciences, Inc. (ENVB.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ENVB.US.md"
symbol: "ENVB.US"
name: "Enveric Biosciences, Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-20T11:27:15.886Z"
locales:
  - [en](https://longbridge.com/en/quote/ENVB.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ENVB.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ENVB.US.md)
---

# Enveric Biosciences, Inc. (ENVB.US)

## Company Overview

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.enveric.com](https://www.enveric.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.36 | 80 | - | - | - |
| PB | 0.83 | 37 | 1.42 | 0.95 | 0.80 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-03-06T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.11 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ENVB.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ENVB.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ENVB.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ENVB.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**